During the past decade, Howell Office Plaza conducted 0 clinical trials. In the 10-year time frame, 0 clinical trials started and 0 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

According to Clinical.Site data, the most researched conditions in "Howell Office Plaza" are "Breast Neoplasms" (1 trials) and "Non Small Cell Lung Carcinoma" (1 trials). Many other conditions were trialed in "Howell Office Plaza" in a lesser frequency.

Most popular intervention types in "Howell Office Plaza" are "Drug" (2 trials). Other intervention types were less common.

The name of intervention was led by "Carboplatin" (1 trials), "Docetaxel, 75 mg/m^2 + Capecitabine, 1000 mg/m^2" (1 trials), "Ixabepilone, 32 mg/m^2 + Capecitabine, 1000 mg/m^2" (1 trials), "Ixabepilone, 40 mg/m^2 + Capecitabine, 1000 mg/m^2" (1 trials) and "Taxotere" (1 trials). Other intervention names were less common.

The vast majority of trials in "Howell Office Plaza" are 2 trials for "All" genders.

Currently, there are NaN active trials in "Howell Office Plaza". undefined are not yet recruiting, undefined are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 1 completed trials in Howell Office Plaza, undefined suspended trials, and 1 terminated clinical trials to date.

Out of the total trials that were conducted in Howell Office Plaza, 0 "Phase 1" clinical trials were conducted, 1 "Phase 2" clinical trials and 1 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".